CNBC January 17, 2025
Annika Kim Constantino

Key Points

– The Biden administration unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare.

– It kicks off the second phase of a landmark provision in the Inflation Reduction Act that aims to make costly medications more affordable for seniors.

– At the top of the list is Novo Nordisk’s blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, which are considered one product since they all share the same active ingredient, semaglutide.

The Biden administration on Friday unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off the second phase of a landmark process that aims to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Medicare, Pharma, Pharma / Biotech
STAT+: Medicare announces plan to negotiate prices of diabetes, weight loss drugs
Congressional Medicare advisors recommend tying radiologist pay increases to inflation
Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP says
Prescription drug cap may save Medicare enrollees thousands: Report
MedPAC recommends to Congress Medicare 2026 payment updates for inpatient, outpatient services

Share This Article